Guided Therapeutics (GTHP) Share-based Compensation Growth (1y) (2012 - 2025)
Guided Therapeutics (GTHP) Share-based Compensation Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -30.44% |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 | 292.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 292.31% |
| Sep 30, 2025 | -6.36% |
| Jun 30, 2025 | 701.38% |
| Mar 31, 2025 | -36.67% |
| Dec 31, 2024 | 75.93% |
| Sep 30, 2024 | -6.04% |
| Jun 30, 2024 | -98.53% |
| Mar 31, 2024 | -99.99% |
| Dec 31, 2023 | -114.06% |
| Sep 30, 2023 | -60.95% |
| Jun 30, 2023 | 2,443.18% |
| Mar 31, 2023 | 1,181.82% |
| Dec 31, 2022 | 440.85% |
| Sep 30, 2022 | -21.43% |
| Jun 30, 2022 | -26.67% |
| Mar 31, 2022 | -29.03% |
| Dec 31, 2021 | 20.53% |
| Sep 30, 2021 | -77.69% |
| Sep 30, 2020 | 8,266.67% |
| Sep 30, 2019 | -78.57% |